These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18061841)

  • 1. Proteomic methods for biomarker discovery in urine.
    Wilkey DW; Merchant ML
    Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.
    Johnston O; Cassidy H; O'Connell S; O'Riordan A; Gallagher W; Maguire PB; Wynne K; Cagney G; Ryan MP; Conlon PJ; McMorrow T
    Proteomics Clin Appl; 2011 Aug; 5(7-8):422-31. PubMed ID: 21751411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteomics and the kidney: an innovative approach to the study of renal disease].
    Netti GS; Rocchetti MT; Papale M; Centra M; Centonze D; Di Paolo S; Ranieri E; Gesualdo L
    G Ital Nefrol; 2008; 25(2):169-82. PubMed ID: 18350497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis.
    Shui HA; Huang TH; Ka SM; Chen PH; Lin YF; Chen A
    Nephrol Dial Transplant; 2008 Jan; 23(1):176-85. PubMed ID: 17881425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
    Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
    Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker discovery in psychiatric disorders.
    Schwarz E; Bahn S
    Electrophoresis; 2008 Jul; 29(13):2884-90. PubMed ID: 18512679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics methods and applications for the practicing clinician.
    Reisdorph NA; Reisdorph R; Bowler R; Broccardo C
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):523-9. PubMed ID: 19558013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
    Fang X; Balgley BM; Lee CS
    Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor proteomics: the past, present and future].
    Xu XE; Jiang YH; Shi Q
    Ai Zheng; 2008 Oct; 27(10):1009-17. PubMed ID: 18851778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteomic analysis and parasitosis: principles and applications].
    Almeras L; Briolant S; Orlandi-Pradines E; Fontaine A; Henry M; Bogreau H; Pradines B; Rogier C; Fusai T
    Med Trop (Mars); 2007 Apr; 67(2):188-96. PubMed ID: 17691442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in human SLE nephritis.
    Rovin BH; Birmingham DJ; Nagaraja HN; Yu CY; Hebert LA
    Bull NYU Hosp Jt Dis; 2007; 65(3):187-93. PubMed ID: 17922668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.
    Thongboonkerd V
    Expert Rev Proteomics; 2005 Jun; 2(3):349-66. PubMed ID: 16000082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.